You may also need to upgrade your Flash Player.
You can upgrade your flash player by Clicking Here »
Press Release for February 10, 2010
Less than a year old, this well-received publication is already making a name for itself in the pharmaceutical publishing world.
February 10, 2010 – BioSupply Trends Quarterly (BSTQ), is pleased to announce that it has been recognized as one of the top 10 pharmaceutical magazines for 2010 by Cision U.S. Inc, a leading media relations firm. This award, which was announced last week, is based on criteria that includes publication scope, depth and audited circulation numbers.
“It is an honor to be acknowledged for our publishing efforts, especially since BSTQ was just launched in July of 2009,” says Patrick M. Schmidt, publisher, BioSupply Trends Quarterly and chief executive officer, FFF Enterprises. “In our first year, we’ve endeavored to produce a magazine that is a content-rich resource for timely, newsworthy and critical information impacting the biopharmaceuticals marketplace. Going forward, we continue to look for ways to add value to what is already a highly respected industry publication.”
Each issue of BSTQ offers in-depth profiles on the leaders and trailblazers within the biopharmaceuticals industry. The magazine also features informative columns, research findings, product news and a valuable resource guide in each issue. The BioDashboard found at the back of each issue offers up-to-date IVIG reimbursement rates and comprehensive IG and Influenza Vaccine reference tables.
“Our vision was to create a publication that offered greater breadth and depth of the timely information we were already providing our customers through our bi-weekly, award-winning BioSupply Trends e-newsletter,” says Sheryl Perez, creative director, BioSupply Trends Quarterly and vice president, marketing and communications, FFF Enterprises. “Each themed issue of BSTQ provides readers with today’s most topical issues, from plasma economics and reimbursement, to vaccine news and the future of biotherapeutics.”
BSTQ reaches more than 50,000 subscribers, including national distribution to general practice physicians, hospital and clinic chiefs of staff and buyers, pharmacy managers and buyers, specialist physicians, and other healthcare professionals. To subscribe to BSTQ or for advertising information visit, www.BSTQuarterly.com or call (800) 843-7477 ext. 1364.
BioSupply Trends Quarterly (BSTQ) is a quarterly magazine published by FFF Enterprises, Inc. BSTQ has a national distribution to general practice physicians, hospital and clinic chiefs of staff and buyers, pharmacy managers and buyers, specialist physicians and other healthcare professionals. The publication’s mission is to serve as the industry’s leading resource for timely, newsworthy and critical information impacting the biopharmaceuticals marketplace, while providing readers with useful tips, trends, perspectives and leading indicators on topics pertinent to their business.
About FFF Enterprises, Inc.
FFF Enterprises, Inc., a privately held corporation, is the largest and most-trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is celebrating its 21st year with more than a billion dollars in annual sales and a flawless safety track record. FFF’s Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to licensed healthcare providers, protecting patients and manufacturers from counterfeit risks and pricing irregularities inherent in secondary and gray market channels. FFF’s proprietary services, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel. FFF’s MyFluVaccine (www.MyFluVaccine.com) has revolutionized the flu marketplace, offering a dedicated flu vaccine supply, delivered to customers on the date of their choosing. FFF’s ability to move rapidly in a dynamically changing marketplace allows the creation of new opportunities for customers through innovative vehicles for distribution.